David J. Ellam

Plethora Solutions Holdings Plc operates as a pharmaceutical company. It engages in the development and marketing of products for the treatment and management of urological disorders. The firm operates through the Plethora Development and The Urology Co. segments. The Plethora Development segment develops new pharmaceutical products. The Urology Co. segment sells and markets pharmaceutical and healthcare products. The company was founded by Michael Grant Wyllie and Neil Brent Stafford in December 2003 and is headquartered in Chalgrove, the United Kingdom.

LyGenesis, Inc. operates as a biotechnology company. It develops an organ regeneration technology platform enabling a patient's lymph nodes to be used as bioreactors to regrow functioning ectopic organs. The company is headquartered in Pittsburgh, PA.

Premier Veterinary Group Plc provides veterinary health care services. It operates through the following segments: Premier Pet Care Plan (PPCP) United Kingdom, PPCP Europe, and PPCP USA. The firm also administers a small animal wellness plan, branded pet care plan both for its own surgeries and for third party surgeries. The company was founded on October 31, 2001 and is headquartered in Bristol, the United Kingdom.